ArticleFrontiers in medicine2026
Cross-sectional comparison of lower-limb muscle strength and contractile properties according to Parkinson's disease and sarcopenia status.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bridging assessment, biomarkers, and interventions: progress in muscle health research.Frontiers in rehabilitation sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This cross-sectional study compares lower-limb isometric strength and tensiomyography-derived contractile properties between patients with Parkinson's disease and age-matched controls across sarcopenia classifications, with predefined covariate control. However, despite the clinical relevance of muscle dysfunction in Parkinson's disease and sarcopenia, TMG-derived assessments of muscle contractile properties remain limited in these populations. PD is a progressive neurodegenerative disorder marked by motor symptoms such as bradykinesia and rigidity, while sarcopenia is an age-related condition characterized by loss of muscle mass and strength. Both contribute to impaired mobility and increased fall risk, though their physiological signatures may differ. In this cross-sectional study, 60 older adults aged 58-85 years (20 with PD and 40 age-matched healthy controls; 39 males, 21 females) were assessed for isometric muscle strength across eight major lower limb movements using a handheld dynamometer, and for muscle contractile properties of four muscles-lateral gastrocnemius, medial gastrocnemius, soleus, and tibialis anterior-using tensiomyography (TMG). Compared to healthy controls, individuals with PD showed prolonged contraction time (Tc, the time between 10 and 90% of maximal contraction) and reduced maximal muscle displacement (Dm, the peak radial displacement of the muscle belly) in the lateral gastrocnemius (e.g., Tc↑: + 23.6%, Dm↓: -17.8%), suggesting neuromuscular impairment. Sarcopenic participants exhibited lower peak isometric strength in hip and knee extension tasks (e.g., -29.5% in hip extension, -26.2% in knee extension based on maximal voluntary contraction), reflecting task-specific deficits likely related to proximal muscle mass loss. While these results are based on cross-sectional data and should be interpreted cautiously, they suggest the presence of differing neuromuscular patterns in PD and sarcopenia. The findings offer preliminary insights into how PD and sarcopenia may differentially affect muscle strength and contractile characteristics, which could inform future research and clinical considerations regarding lower limb function.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.